Acorah Software Products - Accounts Production 16.6.950 true true false true No description of principal activity 12 February 2024 28 February 2025 28 February 2025 15485539 Dr. Silas Egbita Mr Joseph Egbita iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15485539 2024-02-11 15485539 2025-02-28 15485539 2024-02-12 2025-02-28 15485539 frs-bus:PrivateLimitedCompanyLtd 2024-02-12 2025-02-28 15485539 frs-bus:FilletedAccounts 2024-02-12 2025-02-28 15485539 frs-bus:Micro-entities 2024-02-12 2025-02-28 15485539 frs-bus:EntityHasNeverTraded 2024-02-12 2025-02-28 15485539 frs-bus:AuditExempt-NoAccountantsReport 2024-02-12 2025-02-28 15485539 frs-bus:Director1 2024-02-12 2025-02-28 15485539 frs-bus:Director2 2024-02-12 2025-02-28
Registered number: 15485539
DIAMOND CITY GROUP LIMITED
Unaudited Financial Statements
For the Period 12 February 2024 to 28 February 2025
Balance Sheet
Registered number: 15485539
28 February 2025
£
Current assets 1
NET CURRENT ASSETS 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1
NET ASSETS 1
CAPITAL AND RESERVES 1

Notes

1. General Information
DIAMOND CITY GROUP LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 15485539 . The registered office is 167-169 5th Floor, Great Portland Street, London, W1W 5PF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. Silas Egbita
Director
30/12/2025